Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods – LMA PacMed Pty Ltd

Overview

The Therapeutic Goods Act 1989, enacted to regulate the provision of therapeutic goods in Australia, was introduced to address the need for a robust framework ensuring the safety, quality, and efficacy of therapeutic products. The Act establishes a comprehensive system for the regulation of therapeutic goods, including medicines, medical devices, and blood and blood components. The Australian Register of Therapeutic Goods (ARTG) is a central component of this regulatory framework, listing therapeutic goods that meet the required standards for inclusion. The cancellation of entries from the ARTG, such as that for the medical device with ARTG number 198267, is a mechanism to maintain the integrity of the register by removing products that do not comply with the necessary conditions or fail to meet the essential principles for safety and efficacy. The policy objective of the Act is to protect public health by ensuring that only therapeutic goods that are safe, of high quality, and effective are available for use in Australia. This specific cancellation of the entry for a filter, humidifier, and heat/moisture exchanger from the ARTG was published by Rodolfo Ferrari, acting as a delegate of the Secretary to the Department of Health and Ageing under section 41GP of the Therapeutic Goods Act 1989. The cancellation was due to non-compliance by the sponsor, LMA PacMed Pty Ltd, with the condition of inclusion relating to the Essential Principles, and inaccuracies in the certification provided for the intended purpose of the device. The sponsor’s failure to meet these regulatory requirements resulted in the product being removed from the ARTG, effective from 19 April 2013. This action underscores the importance of adherence to regulatory standards and the enforcement mechanisms in place to uphold the quality and safety of therapeutic goods in Australia.

Scope and Application

The publication of the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG) is governed under section 41GP of the Therapeutic Goods Act 1989. This Act applies to any entity sponsoring a medical device for inclusion in the ARTG and ensures that the device meets the specified regulatory requirements, particularly the Essential Principles, which are designed to protect public health and safety. The scope of the Act extends to any person or entity, such as LMA PacMed Pty Ltd, that sponsors a medical device and includes manufacturers like Atos Medical AB, as evidenced in this particular cancellation notice. The Act has a national jurisdictional reach across Australia, covering both Commonwealth and state/territory levels. The exclusions and exemptions from the Act are minimal, with primary focus on ensuring compliance with the Essential Principles and accurate certification. The application of the Act may be further extended or restricted through subordinate instruments, which provide additional regulations and guidelines to enforce the primary legislation. This ensures a comprehensive oversight and regulation of medical devices in Australia, promoting their safety and efficacy.

Key Provisions

The key provision of this legislation is the cancellation of an entry for a kind of medical device from the Australian Register of Therapeutic Goods (ARTG) under section 41GP of the Therapeutic Goods Act 1989 (the Act) (subsection 41GN(1)(b) (f)). This cancellation pertains specifically to a filter, humidifier, and heat/moisture exchanger with an ARTG number 198267. The sponsor of this medical device, LMA PacMed Pty Ltd, and its manufacturer, Atos Medical AB (Sweden), are directly affected by this cancellation. The device was officially cancelled on 8 March 2013, with the cancellation taking effect from 19 April 2013. The reasons cited for this cancellation are non-compliance with the condition of inclusion relating to the Essential Principles, as well as inaccuracies in the certification provided in the application for inclusion. The Act imposes certain obligations on the parties involved. Specifically, the sponsor, LMA PacMed Pty Ltd, must ensure that the medical device complies with the Essential Principles and that the certification made in the application for inclusion in the ARTG is accurate and reflects the intended purpose of the device as stated in the product information. Failure to meet these obligations can result in the cancellation of the device's entry in the ARTG, as seen in this case. The manufacturer, Atos Medical AB (Sweden), also has a responsibility to provide accurate information and ensure that the device meets the necessary standards and requirements set forth by the Therapeutic Goods Administration (TGA). For breaches of these obligations, the Act provides for both civil and criminal consequences. While the specific offences and penalties are not detailed in this particular notification, the Therapeutic Goods Act 1989 generally outlines various offences related to the registration and supply of therapeutic goods. Offences can include supplying therapeutic goods that do not comply with the Act, and penalties may include fines and imprisonment. In cases where the cancellation of an ARTG entry is due to non-compliance with the Essential Principles or incorrect certification, the maximum penalties can be significant, reflecting the serious nature of these breaches. The TGA may also take additional regulatory actions, such as issuing recalls or imposing further restrictions on the supply of the affected medical devices.